Electrodiagnosis

Assure to Attend Investor Conferences in November 2020

Retrieved on: 
Wednesday, November 4, 2020
Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, OTC Markets Group, Forward-looking statement, Branches of biology

DENVER, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that management will participate in the following investor conferences in November 2020:

Key Points: 
  • DENVER, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that management will participate in the following investor conferences in November 2020:
    GCFF Virtual Conference November 5, 2020.
  • Opal Group's Virtual Family Office and Private Wealth Fall Forum November 11-12, 2020.
  • Virtual Fall Investor Summit November 16-18, 2020.
  • Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

EEG and EMG Devices Market Size, Share- Global Industry Analysis, Key Growth Drivers Trends, Segments, Emerging Technologies, Opportunity and Forecast 2020 to 2024 | Technavio

Retrieved on: 
Wednesday, November 4, 2020
Medical devices, Health, Branches of biology, Electrophysiology, Neurophysiology, Electrodiagnosis, Neurotechnology, Brain–computer interfacing, Electroencephalography

The EEG and EMG devices market is poised to grow by USD 740.48 million during 2020-2024 progressing at a CAGR of almost 9% during the forecast period.

Key Points: 
  • The EEG and EMG devices market is poised to grow by USD 740.48 million during 2020-2024 progressing at a CAGR of almost 9% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201104005245/en/
    Technavio has announced its latest market research report titled Global EEG and EMG Devices Market 2020-2024 (Graphic: Business Wire)
    Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The report on the EEG and EMG devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The EEG and EMG devices market analysis include product segment, end-user segment, and geography landscape.

Insights on the Global Intraoperative Neuromonitoring Market to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 4, 2020
Medical devices, Health, Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, Compound annual growth rate, Mergers and acquisitions, Academic disciplines, Articles

The global intraoperative neuromonitoring Market size is valued at $1098.23M by 2019, and is estimated to reach $1,489.12M by 2025, growing at CAGR of 5.3% during the forecast period of 2020-2025.

Key Points: 
  • The global intraoperative neuromonitoring Market size is valued at $1098.23M by 2019, and is estimated to reach $1,489.12M by 2025, growing at CAGR of 5.3% during the forecast period of 2020-2025.
  • North America dominated the Intraoperative Neuromonitoring Market with a share of 4.7% in the year 2019.
  • Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Intraoperative Neuromonitoring Market.
  • In 2019, Intraoperative Neuromonitoring Market share is fragmented by the top ten players present in the market.

US Nuclear and Grapheton Brain Implants to Help Immobilized Patients

Retrieved on: 
Monday, November 2, 2020
Branches of biology, Biology, Electrophysiology, Neurophysiology, Neurotechnology, Brain–computer interfacing, Electrodiagnosis, Electrocorticography, Ecog, Brain, Implant

Neuroscientists stress there is a large unmet demand to develop implantable sensors and the artificial intelligence required to translate the brain signals into specific commands or actions.

Key Points: 
  • Neuroscientists stress there is a large unmet demand to develop implantable sensors and the artificial intelligence required to translate the brain signals into specific commands or actions.
  • Fortunately, Grapheton has already developed various types of implantable brain sensors, including ECoG (electrocorticography- monitoring the electrical activity of the brain), spinal stimulation probes, and brain chemical sensors, all of which are already in use at various research centers.
  • These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
  • Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov , or the companys website at www.usnuclearcorp.com

Assure Holdings Promotes Craig Caviness to Vice President of Corporate Development

Retrieved on: 
Monday, October 26, 2020
Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, IOM, Lluís Companys, Branches of biology

DENVER, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has promoted Craig Caviness to vice president of corporate development from his former role as eastern U.S. territory director.

Key Points: 
  • DENVER, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has promoted Craig Caviness to vice president of corporate development from his former role as eastern U.S. territory director.
  • In addition, Caviness will serve as a team member on Assures mergers and acquisitions, research and innovation and operational performance teams.
  • Craigs primary function in his expanded role will be advancing the Companys proposition to hospitals for outsourcing their IONM service needs to Assure.
  • A doctor of chiropractic and highly experienced intraoperative neurophysiologist technologist, Caviness joined Assure in 2018.

Assure Holdings Launches Marketing Campaign Directed at Medical Device Distributors

Retrieved on: 
Wednesday, October 21, 2020
Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, IOM, Branches of biology

DENVER, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has announced the launching of a digital marketing campaign to bolster its channel program recruiting medical device distributor partners (Distributor Campaign).

Key Points: 
  • DENVER, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has announced the launching of a digital marketing campaign to bolster its channel program recruiting medical device distributor partners (Distributor Campaign).
  • The Distributor Campaign will be driven by Gary Bennett, Assures Vice President of Revenue.
  • The marketing program automates five business growth components across multiple digital channels including: lead generation, prospect nurturing, client engagement, referral generation and workflow automation.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Assure Holdings Announces the Establishment of a New Technologist Training and Education Program

Retrieved on: 
Tuesday, October 20, 2020
Clinical medicine, Medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, Branches of biology

DENVER, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has announced a new education and training program for technologists.

Key Points: 
  • DENVER, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), has announced a new education and training program for technologists.
  • To lead this effort, the Company has appointed Ramesh Vijay to the newly created director of education position.
  • To alleviate the bottleneck for technologists and foster the pipeline necessary for staffing our growth opportunities, Assure is developing our own technologist training program.
  • This will include educating newly hired non board-certified technologists via didactic courses, clinical training and board preparation as well as the development of continuing education and advanced training for the clinical team.

Global Intraoperative Neuromonitoring Market in US- Featuring Accurate Neuromonitoring LLC, Cadwell Industries Inc., Computational Diagnostics Inc., Among Others

Retrieved on: 
Friday, October 16, 2020
Health, Medical devices, Technology, Hospitals, Other Technology, Other Health, Fitness & Nutrition, Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, Trend, Branches of biology

The intraoperative neuromonitoring market in US is poised to grow by USD 955.33 million during 2020-2024 progressing at a CAGR of over 10 % during the forecast period.

Key Points: 
  • The intraoperative neuromonitoring market in US is poised to grow by USD 955.33 million during 2020-2024 progressing at a CAGR of over 10 % during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201015005792/en/
    Technavio has announced its latest market research report titled Intraoperative Neuromonitoring Market in US 2020-2024 (Graphic: Business Wire)
    The report on the intraoperative neuromonitoring market in US provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The intraoperative neuromonitoring market in US analysis includes the type segment, application segment, methodology segment, and end-user segment.

InventHelp Presents Enhanced ECG/EKG Leads (MTN-3378)

Retrieved on: 
Thursday, October 15, 2020
Branches of biology, Medicine, Cardiac electrophysiology, Clinical medicine, Electrodiagnosis, Electrocardiography, Electrophysiology

She developed the TRANSCEND to fulfill the need for a modified set of leads for an ECG/EKG machine.

Key Points: 
  • She developed the TRANSCEND to fulfill the need for a modified set of leads for an ECG/EKG machine.
  • The leads are designed for efficiency and convenience.
  • The design prevents the tangles that can develop with traditional leads.
  • It also eliminates excessive amounts of slack in such leads.

VivaLNK Partners with AMPS, Increasing Accuracy and Reliability for Continuous ECG and Vitals Monitoring

Retrieved on: 
Wednesday, October 14, 2020
Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Electrodiagnosis, Electrocardiography, Electrophysiology, Monitoring, Heart rate, Automated ECG interpretation, Wireless ambulatory ECG

AMPS' continuous ECG recording suite combined with VivaLNK medical wearable sensors provide real-time and retrospective analysis for continuous ECG datasets in remote environments.

Key Points: 
  • AMPS' continuous ECG recording suite combined with VivaLNK medical wearable sensors provide real-time and retrospective analysis for continuous ECG datasets in remote environments.
  • For the study, AMPS is collecting and processing the ECG data from VivaLNK's medical wearable sensors, which can capture ECG and heart rate on a continuous basis 24 hours a day.
  • Continuous monitoring is particularly crucial for detecting and reporting AFib, as other methods can miss an episode, providing inaccurate results.
  • VivaLNK's Continuous ECG Platform has also been seamlessly integrated with the AMPS Continuous ECG Recording Suite, allowing for the direct analysis of recorded data.